| A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxì, C Cammà Hepatology 51 (4), 1274-1283, 2010 | 396 | 2010 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology, 2011 | 357 | 2011 |
| Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease F Bortolotti, G Verucchi, C Cammà, G Cabibbo, L Zancan, G Indolfi, ... Gastroenterology 134 (7), 1900-1907, 2008 | 298* | 2008 |
| Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinè, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 198 | 2018 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 154 | 2016 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 148 | 2015 |
| The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ... Cancer treatment reviews 33 (8), 729-740, 2007 | 146 | 2007 |
| Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension V Di Marco, V Calvaruso, D Ferraro, MG Bavetta, G Cabibbo, E Conte, ... Gastroenterology 151 (1), 130-139. e2, 2016 | 131 | 2016 |
| Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study C Camma, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi, ... Journal of hepatology 42 (4), 535-540, 2005 | 123* | 2005 |
| Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ... Journal of Hepatology 64 (6), 1217-1223, 2016 | 121 | 2016 |
| Epidemiology, risk factors and surveillance of hepatocellular carcinoma G Cabibbo, A Craxi Eur Rev Med Pharmacol Sci 14 (4), 352-355, 2010 | 121 | 2010 |
| Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannavò, S Madonia, ... Alimentary pharmacology & therapeutics 46 (7), 688-695, 2017 | 116 | 2017 |
| Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study G Cabibbo, M Maida, C Genco, P Parisi, M Peralta, M Antonucci, ... World journal of hepatology 4 (9), 256, 2012 | 114* | 2012 |
| Staging systems of hepatocellular carcinoma: a review of literature M Maida, E Orlando, C Cammà, G Cabibbo World Journal of Gastroenterology: WJG 20 (15), 4141, 2014 | 113 | 2014 |
| Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of hepatology 68 (3), 485-492, 2018 | 110 | 2018 |
| Multimodal approaches to the treatment of hepatocellular carcinoma G Cabibbo, F Latteri, M Antonucci, A Craxì Nature Reviews Gastroenterology & Hepatology 6 (3), 159-169, 2009 | 101 | 2009 |
| Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems C Camma, VD Marco, G Cabibbo, F Latteri, L Sandonato, P Parisi, ... Alimentary pharmacology & therapeutics 28 (1), 62-75, 2008 | 100 | 2008 |
| Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ... Journal of Hepatology 61 (2), 333-341, 2014 | 99 | 2014 |
| Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma C Cammà, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ... Hepatology 57 (3), 1046-1054, 2013 | 99 | 2013 |
| Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ... Hepatology 62 (3), 784-791, 2015 | 97 | 2015 |
Calogero CammàSection of Gastroenterology, University of PalermoEmail verificata su unipa.it
